A new type of PrEP injection, requiring only three injections a year, could be on the way. The FDA approved injections of cabotegravir in 2021 as a form of PrEP, to minimize the risk of acquiring HIV.

Pharma giant Gilead Sciences has revealed the results of its first, Phase 1 trial into a once-a-year PrEP injection. The company revealed its results at this week’s Conference on Retroviruses and ...

Please provide your email address to receive an email when new articles are posted on . According to recently published results, there was no association between a single shoulder corticosteroid ...

Most people feel a mixture of anxiety, nervousness, and excitement in the weeks leading up to surgery. It can also be a busy time when people make preparations for their recovery. Doctors stress the ...

MIAMI -- Men receiving collagenase clostridium histolyticum (CCH; Xiaflex) injections for Peyronie's disease had similar levels of overall satisfaction to surgery, and with fewer adverse effects, but ...